Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®As previously a ...

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...

When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Researchers analysed data from 150 adults with T1D, divided into semaglutide, tirzepatide, and control groups.

Both Wegovy and Mounjaro patients typically start on weekly jabs, either 0.25mg or 2.5mg respectively for each drug, for four weeks, before increasing the dosage in stages from there.

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture knockoff versions of Eli Lilly's tirzepatide while a lawsuit plays out.

Novo Nordisk NVO announced that it is launching a new direct-to-patient online pharmacy called NovoCare, which will offer its popular obesity injection, Wegovy (semaglutide), at a discounted price of ...

Last week, Lilly also announced that it is reducing the prices of its 7.5 mg and 10 mg single-dose vials of obesity ... Mounjaro and Zepbound (tirzepatide), from its shortage list in December ...